VEGF-D is expressed in activated lymphoid cells and in tumors of hematopoietic and lymphoid tissues-Reference-Cited by-同舟云学术

VEGF-D is expressed in activated lymphoid cells and in tumors of hematopoietic and lymphoid tissues

Published:2007-01 Issue:10 Volume:48 Page:2014-2021
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Bardelli Monia,Leucci Eleonora,Schürfeld Karin,Bellan Cristiana,Passiatore Giovanni,Rocchigiani Marina,Bartolommei Sabrina,Orlandini Maurizio,Zagursky Jennifer,Lazzi Stefano,De Falco Giulia,Tosi Piero,Oliviero Salvatore,Leoncini Lorenzo

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10428190701540975

Reference35 articles.

1. Angiogenesis in health and disease

2. The biology of VEGF and its receptors

3. Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis

4. VEGFR-3 in adult angiogenesis

5. VEGFR-3 and Its Ligand VEGF-C Are Associated with Angiogenesis in Breast Cancer

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lymphangiogenesis and Stem Cells in Hematological Malignancies;Comprehensive Hematology and Stem Cell Research;2024

2. Tumor microenvironment in Hodgkin lymphoma: novel prognostic factors for assessing disease evolution;Journal of Medicine and Life;2023-08

3. Angiogenesis in Lymph Nodes Is a Critical Regulator of Immune Response and Lymphoma Growth;Frontiers in Immunology;2020-12-03

4. The nuclear matrix protein CIZ1 facilitates localization of Xist RNA to the inactive X-chromosome territory;Genes & Development;2017-05-01

5. Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuli;Leukemia Research;2016-11